Adderall 7.5

   
Google
 
Web NewDrugInformation.com

Adderall 7.5


Drug - Adderall 7.5
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate
Multiple ingredients are in alphabetical order.

Strength - 1.875MG;1.875MG;1.875MG;1.875MG
The potency of the active ingredient(s), Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. May repeat for multiple part products.

Applicant - SHIRE
The firm name holding legal responsibility for Adderall 7.5. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 011522
The FDA assigned number to Adderall 7.5. Format is nnnnnn.

Product Number - 011
The FDA assigned number to identify Adderall 7.5. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 31, 2000
The date Adderall 7.5 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Adderall 7.5. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Adderall 7.5 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Shire Development Inc
The full name of the firm holding legal responsibility for the new application of Adderall 7.5.

Adderall 7.5